Editor's Choice

Editors' Pick

The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.

Levine DA, Sussman JB, Hayward RA, Gałecki AT, Whitney RT, Briceño EM, Gross AL, Giordani BJ, Elkind MSv, Gottesman RF, et al.

J Alzheimers Dis. 2025 Jan 08:13872877241302506. PMID: 39772767. Abstract

Editors' Pick

Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.

Grau-Jurado P, Mostafaei S, Xu H, Mo M, Petek B, Kalar I, Naia L, Kele J, Maioli S, Pereira JB, et al.

J Alzheimers Dis. 2025 Jan 08:13872877241307870. PMID: 39772858. Abstract

Editors' Pick

Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease.

Costa ASofia, Exalto LG, van der Flier WM, Teunissen CE, Barkhof F, Kuijf HJ, Biessels GJan, TRACE-VCI study group

J Alzheimers Dis. 2024 Dec 28; 102(4):981-986. PMID: 39529285. Abstract

Editors' Pick

Social support may buffer the effect of ε4 allele on cognition in older adults.

Payen A, Bateman JR, Muralidhara SDhanavanth, Sachs BC, Cleveland M, Yang M, Lockhart SN, Craft S, Bennett JM

J Alzheimers Dis. 2024 Dec 28; 102(4):967-974. PMID: 39584285. Abstract

Editors' Pick

Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.

Yau YFung, Cheah IK, Mahendran R, Tang RMy, Chua RYuan, Goh RES, Feng L, Li J, Kua EHeok, Chen C, et al.

J Alzheimers Dis. 2024 Dec 14; 102(3):841-854. PMID: 39544014. Abstract

Editors' Pick

Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-β positive and negative mild cognitive impairment.

Keith CM, Haut MW, Teixeira CVieira Lig, Mehta RI, Phelps H, Ward M, Miller M, R Navia O, Coleman MM, Marano G, et al.

J Alzheimers Dis. 2024 Dec; 102(3):778-791. PMID: 39670736. Abstract

Editors' Pick

Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.

Ishii K, Yamada T, Hanaoka K, Kaida H, Kojita Y, Kono A, Hanada K, Saigoh K, Sakuta S, Hashimoto M, et al.

J Alzheimers Dis. 2024 Nov; 102(1):228-236. PMID: 39497313. Abstract

Editors' Pick

The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities.

Ururahy RDos Reis, Val MScott do, Ciciliati AMaria Maca, Leite RElaine Par, Paes VRibeiro, Rodrigues RDiehl, Grinberg LTenenholz, Pasqualucci CAugusto, Filho WJacob, Suemoto CKimie

J Alzheimers Dis. 2024 Sep 24; 101(3):773-785. PMID: 39213060. Abstract

Editors' Pick

Small Vessel Disease Burden Predicts Incident Dementia and Poor Functional Outcome in Independent Outpatients.

Kitagawa K, Toi S, Hosoya M, Seki M, Yamagishi S, Hoshino T, Yoshizawa H

J Alzheimers Dis. 2024 Sep 24; 101(3):751-760. PMID: 39269832. Abstract

Editors' Pick

A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.

Guo H, Sun S, Yang Y, Ma R, Wang C, Zheng S, Wang X, Li G, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium

J Alzheimers Dis. 2024 Sep 24; 101(3):923-936. PMID: 39240641. Abstract

Main menu

User Top Menu

Pages

You are here

Editor's Choice

Pages